Donor Egg in Vitro Fertilization (IVF) Services Market Report 2026

The donor egg in vitro fertilization (ivf) services market size has grown rapidly in recent years. It will grow from $3.33 billion in 2025 to $3.72 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to increasing infertility rates, maternal age growth, ivf clinical success improvements, donor egg availability expansion, regulatory approvals for fertility treatments.

The donor egg in vitro fertilization (ivf) services market size is expected to see rapid growth in the next few years. It will grow to $5.51 billion in 2030 at a compound annual growth rate (CAGR) of 10.4%. The growth in the forecast period can be attributed to cross-border fertility tourism, genetic screening demand, personalized fertility protocols, clinic network expansion, insurance coverage improvements. Major trends in the forecast period include rising demand for donor egg ivf due to delayed parenthood, growing acceptance of assisted reproductive technologies, expansion of frozen donor egg programs, increased use of pre-implantation genetic testing, growth of specialized fertility clinics.

The rising infertility rate is expected to drive the growth of the donor egg IVF services market in the coming years. Infertility is defined as the inability to conceive or carry a pregnancy to term after 12 months or more of regular, unprotected intercourse. The increase in infertility is influenced by factors such as untreated sexually transmitted infections, delayed childbearing, and limited access to modern reproductive healthcare. The donor egg IVF services market supports this trend by providing the option to conceive using eggs from fertile donors, offering a viable solution for individuals and couples unable to achieve pregnancy naturally. For example, in March 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, of the 3,596,017 live births in the United States in 2023, 88,185 births (2.45%) resulted from infertility treatment, with rates increasing with maternal age from 0.2 per 1,000 for mothers under 20 to 120 per 1,000 for mothers aged 40-54. Therefore, the rising infertility rate is driving the growth of the donor egg IVF services market.

Companies in the donor egg in vitro fertilization (IVF) services market are focusing on developing advanced technological solutions, such as artificial intelligence (AI)-powered IVF systems, to improve embryo selection accuracy, enhance success rates, and optimize patient outcomes. AI-powered IVF solutions refer to digital platforms that use machine-learning algorithms and data analytics to support clinical decisions, streamline laboratory workflows, and improve the reliability and efficiency of IVF procedures. For instance, in September 2023, AIVF, an Israel-based software development company, launched EMA, an AI-powered IVF operating system designed to enhance decision-making in IVF clinics, optimize operations, and strengthen communication between clinics and patients. EMA incorporates deep learning models trained on extensive datasets and features an embryo evaluation module that increases workflow efficiency and delivers 38% higher accuracy than traditional embryologist assessments, supporting more precise and effective IVF treatments.

In April 2024, Ivy Fertility, a US-based infertility center, acquired Dallas IVF for an undisclosed amount. Through this acquisition, Ivy Fertility aims to expand its national network of fertility centers and enhance its reproductive healthcare offerings across the United States. Dallas IVF is a US-based fertility center specializing in a broad range of fertility treatments and reproductive services.

Major companies operating in the donor egg in vitro fertilization (ivf) services market are Raffles Medical Group, United Family Healthcare, Thomson Medical Group, Virtus Health, Genetics & IVF Institute, Fertility Associates, SAFE Fertility Center, TMC Fertility, TRIO Fertility, Sims IVF, Procrea Fertility, KL Fertility Centre, Morpheus Life Sciences Pvt Ltd, Bourn Hall Fertility Center, The Montreal Fertility Center, Cape Fertility Clinic, ReproMed Fertility Clinics, Merrion Fertility Clinic, Medfem Fertility Clinic, Flinders Fertility, Fertility First, Cloudnine Fertility, Beacon CARE Fertility, Aevitas Fertility Clinic.

North America was the largest region in the donor egg in vitro fertilization (IVF) services market in 2025. The regions covered in the donor egg in vitro fertilization (ivf) services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the donor egg in vitro fertilization (ivf) services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the donor egg IVF services market by increasing costs of imported fertility drugs, laboratory media, cryopreservation equipment, and genetic testing reagents. Fertility clinics in North America and Europe are most affected due to reliance on imported consumables, while emerging markets face affordability challenges. These tariffs raise treatment costs but also encourage local manufacturing of ivf consumables and regional laboratory capability development.

The donor egg in vitro fertilization (ivf) services market research report is one of a series of new reports that provides donor egg in vitro fertilization (ivf) services market statistics, including donor egg in vitro fertilization (ivf) services industry global market size, regional shares, competitors with a donor egg in vitro fertilization (ivf) services market share, detailed donor egg in vitro fertilization (ivf) services market segments, market trends and opportunities, and any further data you may need to thrive in the donor egg in vitro fertilization (ivf) services industry. This donor egg in vitro fertilization (ivf) services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Donor egg in vitro fertilization (IVF) services are fertility treatments in which eggs from a donor are used to help an individual or couple conceive a child. The process involves fertilizing a donor woman’s eggs with sperm in a laboratory and is designed for mothers who cannot use their own eggs due to age, medical conditions, or genetic factors.

The main offerings of donor egg in vitro fertilization (IVF) services include in vitro fertilization (IVF) drugs, IVF media and reagents, IVF procedures, and intrauterine insemination (IUI) services. IVF drugs are medications used during the IVF process to stimulate the ovaries, regulate ovulation, and prepare the body for egg retrieval and embryo transfer. The services include procedures such as fresh donor eggs, frozen donor eggs, and others, and are utilized by end users including clinical research institutes, surgical centers, hospitals, fertility clinics, and more.

The donor egg in vitro fertilization (IVF) services market includes revenues earned by entities through donor recruitment and matching, screening and evaluation, and laboratory services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.